A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
Public ClinicalTrials.gov record NCT00791258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-Label, Titration Study to Evaluate the Efficacy and Safety Safety of AZOR in Multiple Subgroups of Hypertensive Subjects Who Are Non-Responders to Anti-Hypertensive Monotherapy
Study identification
- NCT ID
- NCT00791258
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 999 participants
Conditions and interventions
Conditions
Interventions
- amlodipine and olmesartan medoxomil tablets Drug
- hydrochlorothiazide tablets Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2008
- Primary completion
- Jul 31, 2009
- Completion
- Aug 31, 2009
- Last update posted
- Jan 8, 2019
2008 – 2009
United States locations
- U.S. sites
- 72
- U.S. states
- 29
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Green Valley | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Sierra Vista | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Harbor City | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Pueblo | Colorado | — | — |
| Not listed | Milford | Connecticut | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Deerfield Beach | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Addison | Illinois | — | — |
| Not listed | Orland Park | Illinois | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Columbia | Maryland | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Oxon Hill | Maryland | — | — |
| Not listed | Reisterstown | Maryland | — | — |
| Not listed | Stevensville | Michigan | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Edison | New Jersey | — | — |
| Not listed | Sewell | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Binghamton | New York | — | — |
| Not listed | Cary | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Harrisburg | North Carolina | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Havertown | Pennsylvania | — | — |
| Not listed | Jenkintown | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | New Tazewell | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Longview | Texas | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Walla Walla | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00791258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2019 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00791258 live on ClinicalTrials.gov.